SYNDYMA 400MG/16ML INJECTION

SYNDYMA 400MG/16ML INJECTION is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to SYNDYMA 400MG/16ML INJECTION, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

SYNDYMA 400MG/16ML INJECTION is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28 days before or after surgery.

All the side effects that are relatively caused by SYNDYMA 400MG/16ML INJECTION occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

SYNDYMA 400MG/16ML INJECTION is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with SYNDYMA 400MG/16ML INJECTION in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

It is important to inform your doctor about all the medicines you are currently taking, including prescription, over-the-counter, and herbal supplements, as SYNDYMA 400MG/16ML INJECTION may interact with some medications. Your doctor will determine if it is safe to take them together.

It is vital to inform your physician before taking SYNDYMA 400MG/16ML INJECTION if you have the following conditions: Have conditions involving inflammation in the stomach (ulcer, colitis). Experience allergic reactions to SYNDYMA 400MG/16ML INJECTION or its ingredients. Have recently undergone surgery as it is associated with the risk of bleeding. Have diabetes, hypertension, or heart problems.

The active ingredient in SYNDYMA 400MG/16ML INJECTION is Bevacizumab.

SYNDYMA 400MG/16ML INJECTION is used to treat various types of cancers. It works by targeting and blocking a protein called VEGF, which helps tumors grow blood vessels.

SYNDYMA 400MG/16ML INJECTION is an anti-cancer medication that works by stopping the growth of new blood vessels that tumors need to grow and spread. This helps slow down or stop cancer growth.